Cargando…
Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma
Treatment effectiveness in hepatocellular carcinoma (HCC) depends on early detection and precision-medicine-based patient stratification for targeted therapies. However, the lack of robust biomarkers, particularly a non-invasive diagnostic tool, precludes significant improvement of clinical outcomes...
Autores principales: | Pomyen, Yotsawat, Budhu, Anuradha, Chaisaingmongkol, Jittiporn, Forgues, Marshonna, Dang, Hien, Ruchirawat, Mathuros, Mahidol, Chulabhorn, Wang, Xin Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187378/ https://www.ncbi.nlm.nih.gov/pubmed/34103600 http://dx.doi.org/10.1038/s41598-021-91560-1 |
Ejemplares similares
-
Functional Genomic Complexity Defines Intratumor Heterogeneity and Tumor Aggressiveness in Liver Cancer
por: Kwon, So Mee, et al.
Publicado: (2019) -
Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
por: Pomyen, Yotsawat, et al.
Publicado: (2023) -
Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma
por: Hung, Man Hsin, et al.
Publicado: (2021) -
Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis
por: Schäffer, Alejandro A., et al.
Publicado: (2021) -
Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma
por: Takai, Atsushi, et al.
Publicado: (2016)